Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human Vα24+Vβ11+ T cells in vitro

Human Immunology

Volumn 61, Issue 4, 2000, Pages 357-365

  Nishi, Nobusuke ^a   Van Der Vliet, Hans J J ^a   Koezuka, Yasuhiko ^a   Von Blomberg, B Mary E ^b   Scheper, Rik J ^b   Pinedo, Herbert M ^a   Giaccone, Giuseppe ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

Galactosylceramide; Granzyme B; Interleukin; NK T cell; Perforin

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; DRUG SYNERGISM; GALACTOSYLCERAMIDES; GRANZYMES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-7; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SERINE ENDOPEPTIDASES; T-LYMPHOCYTE SUBSETS;

EID: 0034122442     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00181-0     Document Type: Article

References (36)

1. Natori T., Morita M., Akimoto K., Koezuka Y. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus. Tetrahedron. 50:1994;2771.
2. Morita M., Motoki K., Akimoto K., Natori T., Sakai T., Sawa E., Yamaji K., Koezuka Y., Kobayashi E., Fukushima H. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J Med Chem. 38:1995;2176.
3. Nakagawa R., Motoki K., Ueno H., Iijima R., Nakamura H., Kobayashi E., Shimosaka A., Koezuka Y. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res. 58:1998;1202.
4. Yamaguchi Y., Motoki K., Ueno H., Maeda K., Kobayashi E., Inoue H., Fukushima H., Koezuka Y. Enhancing effects of (2S, 3S, 4R)-1-O-(α-D-galactopyranosyl)-2-(N-hexacosanoylamino)-1, 3, 4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells. Oncol Res. 8:1996;399.
5. - T cells. J Exp Med. 180:1994;1171.
6. Porcelli S., Gerdes D., Fertig A.M., Balk S.P. Human T cells expressing an invariant Vα24-JαQ TCRα are CD4- and heterogeneous with respect to TCRβ expression. Hum Immunol. 48:1996;63.
7. - T cells. J Exp Med. 186:1997;109.
8. Davodeau F., Peyrat M.A., Necker A., Dominici R., Blanchard F., Leget C., Gaschet J., Costa P., Jacques Y., Godard A., Vié H., Poggi A., Romagné F., Bonneville M. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J Immunol. 158:1997;5603.
9. - T cells bearing T-cell receptor α and β chains in two normal men. Blood. 79:1992;2965.
10. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1997;1626.
11. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., Kronenberg M. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 188:1998;1521.
12. Spada F.M., Koezuka Y., Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med. 188:1998;1529.
13. + NK T lymphocytes . J Immunol. 161:1998;3271.
14. Nieda M., Nicol A., Koezuka Y., Kikuchi A., Takahashi T., Nakamura H., Furukawa H., Yabe T., Ishikawa Y., Tadokoro K., Juji T. Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum Immunol. 60:1999;10.
15. + T cell development and early IL-4 production in CD1-deficient mice. Immunity. 6:1997;459.
16. Mendiratta S.K., Martin W.D., Hong S., Boesteanu A., Joyce S., van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:1997;469.
17. + cell development . J Immunol. 159:1997;5931.
18. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 9:1998;669.
19. Boesteanu A., De Silva A.D., Nakajima H., Leonard W.J., Peschon J.J., Joyce S. Distinct roles for signals relayed through the common cytokine receptor γ chain and interleukin 7 receptor α chain in natural T cell development. J Exp Med. 186:1997;331.
20. Noguchi M., Nakamura Y., Russell S.M., Ziegler S.F., Tsang M., Cao X., Leonard W.J. Interleukin-2 receptor γ chain a functional component of the interleukin-7 receptor . Science. 262:1993;1877.
21. + T) cells, natural killer cells, and intestinal intraepithelial T cells . J Exp Med. 187:1998;967.
22. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., Kondo E., Harada M., Koseki H., Nakayama T., Tanaka Y., Taniguchi M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci USA. 95:1998;5690.
23. Brossay L., Naidenko O., Burdin N., Matsuda J., Sakai T., Kronenberg M. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J Immunol. 161:1998;5124.
24. Liu C.C., Young L.H.Y., Young J.D.E. Mechanisms of disease lymphocyte-mediated cytolysis and disease . N Engl J Med. 335:1996;1651.
25. Talanian R.V., Yang X.H., Turbov J., Seth P., Ghayur T., Casiano C.A., Orth K., Froelich C.J. Granule-mediated killing pathways for granzyme B-initiated apoptosis . J Exp Med. 186:1997;1323.
26. Padovan E., Casorati G., Dellabona P., Meyer S., Brockhaus M., Lanzavecchia A. Expression of two T cell receptor α chains dual receptor T cells . Science. 262:1993;422.
27. Kummer J.A., Kamp A.M., van Katwijk M., Brakenhoff J.P.J., Radosevic K., van Leeuwen A.M., Borst J., Verweij C.L., Hack C.E. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins. J Immunol Methods. 163:1993;77.
28. Wever P.C., Mulder J.B.G., Weening J.J., ten Berge I.J.M. Immunocytochemical detection of granzymes A and B in peripheral blood lymphocytes from healthy individuals after non-enzymatic antigen retrieval. J Histochem Cytochem. 45:1997;467.
29. Porcelli S.A., Modlin R.L. The CD1 system antigen-presenting molecules for T cell recognition of lipids and glycolipids . Annu Rev Immunol. 17:1999;297.
30. Caux C., Lebecque S., Liu Y.J., Banchereau J. Developmental pathways of human myeloid dendritic cells. Lotze M.L., Thomson A.W. Dendritic cells Biology and clinical applications . 1999;Academic Press, London.
31. +-T cells. Immunology. 98:1999;557.
32. Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Rückert R., Krause H., Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med. 3:1997;1124.
33. -/- mice. Cell. 89:1997;1011.
34. Eberl G., MacDonald H.R. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice a major role for bone marrow in NKT cell homeostasis . Immunity. 9:1998;345.
35. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L.S., Cosman D., Anderson D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:1994;2822.
36. Sumida T., Sakamoto A., Murata H., Makino Y., Takahashi H., Yoshida S., Nishioka K., Iwamoto I., Taniguchi M. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med. 182:1995;1163.